(Total Views: 487)
Posted On: 02/13/2021 4:45:49 PM
Post# of 145886
Quote:
Eli Lilly's baricitinib JAK inhibitor.
Leronlimab downregulates Jak1 and JAK2. So many drugs with such limited MOAs.
(2)
(0)